Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Michael Jain

Associate Member

H Lee Moffitt Cancer Center and Research Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (22)

Nasheed Hossain

Assistant Professor of Medicine

University of Pennsylvania

UNITED STATES

View details

Amit Maity

Professor and Chair of Dept. of Radiation Oncology

University of Utah

UNITED STATES

View details

Akshay S Bedmutha

Assistant Professor

Emory University

UNITED STATES

View details

Ran Reshef

University of Pennsylvania

UNITED STATES

View details

Anna Barata

Massachusetts General Hospital

UNITED STATES

View details

Johannes Fahrmann

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

David B Miklos

Stanford University

UNITED STATES

View details

Yolanda Tseng

Professor

University of Washington

UNITED STATES

View details

Gunjan Shah

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Miriam Jacobs

Georgetown University

UNITED STATES

View details

Leo Hansmann

GERMANY

View details

Marion Subklewe

University Hospital

GERMANY

View details

Jongphil Kim

Professor

Moffitt Cancer Center

UNITED STATES

View details

Jay Spiegel

Assistant Professor

University of Miami

UNITED STATES

View details

Philipp Altrock

Resarch Group Leader

University Hospital Schleswig-Holstein

GERMANY

View details

Tomas Jelinek

CZECH REPUBLIC

View details

Neeraj Y Saini

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Marion Subklewe

LMU University Hospital

GERMANY

View details

Tania Jain

UNITED STATES

View details

Timothy Robinson

Assistant Professor

Yale University

UNITED STATES

View details

Siqi Zhang

University of Pennsylvania

UNITED STATES

View details

Alaa Ali

Georgetown University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Jain

Research Interests

Explore related searches

Articles (20)

Spectrum, pathobiology, mechanistic insights and diagnostic challenges of post-CAR T cell therapy lymphoproliferative disorders

Prospective cohort study of immunosuppression taper and discontinuation after allogeneic stem cell transplantation

Clinical Features and Outcomes of Therapy-Related Myeloid Neoplasms After CAR T-Cell Therapy

Beyond Hospital Discharge: Defining Outpatient Care After Tumor-Infiltrating Lymphocyte Therapy

Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies

Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study

Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma

Noncanonical and mortality-defining toxicities of CAR T cell therapy

Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies

Immune dysfunction after cancer remission: scar or disease?

Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing

Easy as ABC: Managing Toxicities of Antibody-Drug Conjugates, Bispecific Antibodies, and CAR T-Cell Therapies

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy

Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma

Axicabtagene Ciloleucel in Combination with the 4–1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11

Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome

Collaborators (22)

Nasheed Hossain

Amit Maity

Akshay S Bedmutha

Ran Reshef

Anna Barata

Johannes Fahrmann

David B Miklos

Yolanda Tseng

Gunjan Shah

Miriam Jacobs

Leo Hansmann

Marion Subklewe

Jongphil Kim

Jay Spiegel

Philipp Altrock

Tomas Jelinek

Neeraj Y Saini

Marion Subklewe

Tania Jain

Timothy Robinson

Siqi Zhang

Alaa Ali

Make your next move.